Psychiatric disorders in primary focal dystonia and in Parkinson's disease

Neuropsychiatric Disease and Treatment

Volumn 7, Issue 1, 2011, Pages 111-116

  Dias, Fernando M V ^a   Kummer, Arthur ^a   Doyle, Flávia C P ^b   Harsányi, Estefânia ^a   Cardoso, Francisco ^b   Fontenelle, Leonardo F ^c   Teixeira, Antônio Lúcio ^a  

^a Neuropsychiatric Branch   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Depression; Focal dystonia; Neuropsychiatry; Obsessivecompulsive disorder; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; BRAIN TISSUE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; FOCAL DYSTONIA; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MICROMORPHOLOGY; MONOAMINE NERVE CELL; NEUROBIOLOGY; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGIC ASSESSMENT; TREATMENT DURATION;

EID: 80053646831     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S17507     Document Type: Article

References (43)

1. Kummer A, Teixeira AL. Parkinson's disease and obsessive-compulsive phenomena: A systematic review. Curr Psychiatry Rev. 2009;5(1): 55-61.
2. Maia DP, Teixeira AL, Cunningham MC, Cardoso F. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology. 2005;24;64(10):1799-801.
3. Defazio G, Abbruzzese G, Livrea P, Berardelli A. Epidemiology of primary dystonia. Lancet Neurol. 2004;3(11):673-678.
4. Carvalho Aguiar PM, Ozelius LJ. Classification and genetics of dystonia. Lancet Neurol. 2002;1(5):316-325.
5. Calne D. A definition of Parkinson's disease. Parkinsonism Relat Disord.2005;11 Suppl 1:S39-S40.
6. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211.
7. Kummer A, Teixeira AL. Neuropsychiatry of Parkinson's disease. Arq Neuropsiquiatr. 2009;67(3B):930-939.
8. Scalzo P, Kummer A, Cardoso F, Teixeira AL. Depressive symptoms and perception of quality of life in Parkinson's disease. Arq Neuropsiquiatr.2009;67(2A):203-208.
9. Dias FMV, Doyle F, Kummer A, Cardoso F, Fontenelle LF, Teixeira AL. Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm. Acta Neuropsychiatr. 2010;22(5):223-227.
10. Gündel H, Wolf A, Xidara V, et al. High psychiatric comorbidity in spasmodic torticollis: A controlled study. J Nerv Ment Dis. 2003;191(7): 465-473.
11. Hall TA, McGwin G Jr, Searcey K, et al. Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch Ophthalmol. 2006;124(1):116-119.
12. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004;110(2):118-123.
13. Fahn S, Eldridge R. Definition of dystonia and classification of the dystonic states. Adv Neurol. 1976;14:1-5.
14. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the Mini-Mental State Examination in Brazil. Arq Neuropsiquiatr. 2003;61(3B):777-781.
15. Amorim P. Mini International Neuropsychiatric Interview (MINI): validation of a short structured diagnostic psychiatric interview. Rev Bras Psiquiatr. 2000;22(3):106-115.
16. Araújo LA. Escalas de avaliação de transtorno obsessivo compulsivo em adultos. [Rating Scales for Obsessive Compulsive Disorder in Adults.] Rev Psiq Clin. 1998;25(6):307-309.
17. Gorenstein C, Andrade L. Beck Depression Inventory: psychometric properties of the Portuguese version. Rev Psiquiatr Clin. 1998;25(5):245-250.
18. Kummer A, Cardoso F, Teixeira AL. Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease. Arq Neuropsiquiatr.2010;68(4):495-501.
19. Terra MB, Barros HMT, Stein AT, et al. Internal consistency and factor structure of the Portuguese version of the Liebowitz Social Anxiety Scale among alcoholic patients. Rev Bras Psiquiatr. 2006;28(4):265-269.
20. Miller KM, Okun MS, Fernandez HF, Jacobson CE, Rodrigues RL, Bowers D. Depression symptoms in movement disorders: Comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord.2007;22(5):666-672.
21. Lauterbach EC, Freeman A, Vogel RL. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2004;16(1):29-36.
22. Kummer A, Teixeira AL. Depressive disorders in Parkinson's disease may be due to a shared immune-mediated neurodegenerative process. Med Hypotheses. 2008;70(1):201-202.
23. Scalzo P, Kümmer A, Cardoso F, Teixeira AL. Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance. Neurosci Lett. 2010;468(1):56-58.
24. Scalzo P, Kümmer A, Cardoso F, Teixeira AL. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. J Neuroimmunol. 2009;216(1-2):122-125.
25. Tanabe LM, Kim CE, Alagem N, Dauer WT. Primary dystonia: Molecules and mechanisms. Nat Rev Neurol. 2009;5(11):598-609.
26. Beer K. Cost effectiveness of botulinum toxins for the treatment of depression: Preliminary observations. J Drugs Dermatol. 2010;9(1): 27-30.
27. Munts AG, Koehler PJ. How psychogenic is dystonia? Views from past to present. Brain. 2010;133(5):1552-1564.
28. Cavallaro R, Galardi G, Cavallini MC, et al. Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry. 2002;52(4):356-361.
29. Lencer R, Steinlechner S, Stahlberg J, et al. Primary focal dystonia: Evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry. 2009;80(10):1176-1179.
30. Bihari K, Hill JL, Murphy DL. Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollis. Psychiatry Res. 1992; 42(3):267-272.
31. Wenzel T, Schnider P, Wimmer A, Steinhoff N, Moraru E, Auff E. Psychiatric comorbidity in patients with spasmodic torticollis. J Psychosom Res. 1998;44(6):687-690.
32. Munhoz RP, Teive HA, Della Coletta MV, et al. Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm. Arq Neuropsquiatr. 2005;63(2A):213-216.
33. Fabbrini G, Berardelli I, Moretti G, et al. Psychiatric disorders in adultonset focal dystonia: A case-control study. Mov Disord. 2010;25(4): 459-465.
34. Pacheco PG, Nascimento PM, Lauterbach EC, et al. Obsessivecompulsive symptoms among patients with blepharospasm and hemifacial spasm. CNS Spectrums. In press.
35. Gündel H, Wolf A, Xidara V, Busch R, Ceballos-Baumann AO. Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry.2001;71(4):499-504.
36. Kummer A, Cardoso F, Teixeira AL. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease. Mov Disord. 2008;23(12):1739-1743.
37. Lauterbach EC, Freeman A, Vogel RL. Correlates of generalized anxiety and panic attacks in dystonia and Parkinson disease. Cogn Behav Neurol. 2003;16(4):225-233.
38. Hess CW, Raymond D, Aguiar PC, et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology. 2007;68(7):522-524.
39. Haque FN, Gottesman II, Wong AH. Not really identical: Epigenetic differences in monozygotic twins and implications for twin studies in psychiatry. Am J Med Genet C Semin Med Genet. 2009;151C(2): 136-141.
40. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, ''prefrontal'' and''limbic'' functions. Prog Brain Res. 1990;85:119-146.
41. Kessler RC. The impairments caused by social phobia in the general population: Implications for intervention. Acta Psychiatr Scand. 2003; 417 (Suppl):19-27.
42. Guitton MJ, Klin Y, Dudai Y. Taste-dependent sociophobia: When food and company do not mix. Behav Brain Res. 2008;191(2):148-152.
43. Winter Y, von Campenhausen S, Popov G, et al. Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study. Parkinsonism Relat Disord. 2010;16(4):243-248.